AlphaGrep UK Ltd’s Corpay CPAY Stock Holding History

AlphaGrep UK Ltd’s Portfolio CPAY Stock Details CPAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-731	Closed	-$220K	–	951
2025 Q4	$220K	Buy	+731	New	+$212K	0.07%	591

Other funds holding CPAY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

AlphaGrep UK Ltd's CPAY Position: Q1 2026 in Review

AlphaGrep UK Ltd sold out of Corpay (CPAY) in Q1 2026, closing a stake of 731 shares — an estimated $220K sold.

AlphaGrep UK Ltd first reported a position in CPAY in Q4 2025 and held it in 1 quarter. The position peaked at $220K in Q4 2025. 682 funds tracked by Wall St. Rank hold CPAY as of Q1 2026.

AlphaGrep UK Ltd reported no remaining Corpay position as of Q1 2026 after selling out during the quarter.
AlphaGrep UK Ltd sold 731 Corpay shares in Q1 2026, an estimated $220K.
AlphaGrep UK Ltd first reported a position in Corpay in Q4 2025 and held it in 1 quarter.
AlphaGrep UK Ltd's Corpay position peaked at $220K in Q4 2025.
682 funds tracked by Wall St. Rank held Corpay as of Q1 2026.

Based on AlphaGrep UK Ltd's 13F filing for Q1 2026, filed 13 Aug 2026.